Home Glytec

Glytec

In operation
-
Digital Therapeutics Service Provider for Diabetes
Basic
Enterprise Profile

Basic Information

Glytec develops clinical information technology to help improve insulin management and blood glucose control. The company's system is prescriptive guidance software for safe and effective blood glucose management across the entire hospital, enabling them to serve patients with diabetes and those experiencing blood glucose fluctuations due to trauma, drug reactions, stress, and other factors. The company’s patented and FDA-approved software acts as a medical device solution that enhances the safety and health of people with diabetes and makes insulin a more effective medication option for millions unable to achieve treatment goals. Glytec combines evidence-based decision support technology with expert clinical services to optimize basal and bolus insulin therapy in both hospital and home settings, reducing hypoglycemia and other complications, as well as avoidable emergency visits, hospitalizations, readmissions, and medication waste.
Glytec, LLC
Boston,Massachusetts,United States of America
51~100 people
January 01, 2006
info@glytec.com

Enterprise Profile

Industrial Sector
Information Technology Vendors
Concept
# Diabetes Mellitus
Application Scenarios
Digital Therapeutics SaaS service Medical Software